Cardiol Therapeutics Inc.

Healthcare

NASDAQ:CRDL · NASDAQ Capital Market

Market Cap $117.47M Beta 0.80 P/E (TTM) -4.4

$1.03 -3.74%

-$0.04 today

52W Low $0.88High $1.71

Vol 0.24M · Avg 0.69M

EPS (TTM)-$0.33

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-29.45%

Period High

$1.63

Period Low

$0.93

Latest

$1.03

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Assertio Holdings, Inc.

NASDAQ:ASRT

$151.73M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$133.48M

InflaRx N.V.

NASDAQ:IFRX

$115.57M

Hyperfine, Inc.

NASDAQ:HYPR

$114.53M

Microbot Medical Inc.

NASDAQ:MBOT

$81.12M

Kalaris Therapeutics Inc

NASDAQ:KLRS

$80.98M

Vivani Medical, Inc.

NASDAQ:VANI

$64.99M

ImageneBio Inc

NASDAQ:IMA

$63.39M

InterCure Ltd.

INCR

$47.79M

InspireMD, Inc.

NSPR

$34.19M

What is the latest CRDL filing?

The latest filing shown is 6-K dated May 26, 2026.

How many recent filings does CRDL have?

Intrinsic Alpha currently shows 20 recent filings for CRDL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.